Treatment options for managing your PH will depend on what type of pulmonary hypertension you have. Each type of pulmonary hypertension requires a tailored treatment plan that follows the latest ...
Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...
The incidence of pulmonary arterial hypertension (PAH) has increased worldwide over the past three decades, although death rates and disability-adjusted life year (DALY) rates related to the disease ...
Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious condition that can impair blood flow, ...
In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since. After the FDA approved both ...
Anderson Cooper, anchor of CNN's "Anderson Cooper 360," has contributed to 60 Minutes since 2006. His exceptional reporting on big news events has earned Cooper a reputation as one of television's ...
When most people hear the word hypertension, they think of high blood pressure. While not as common as high blood pressure, pulmonary hypertension, which affects the lungs, can be harder to diagnose, ...
No one was sure what a Kamala Harris presidency would mean for Lina Khan, the controversial chair of the Federal Trade Commission (FTC) appointed by President Joe Biden. But with Harris, too, on her ...
1 School of Physical Education, Xi’an Fanyi University, Xi’an, China 2 School of Physical Education, Shaanxi Normal University, Xi’an, China Pulmonary hypertension is a progressive disease of the ...
BOSTON -- Sodium-glucose cotransporter-2 (SGLT2) inhibitors were linked to long-term reductions in mortality risk among patients with pulmonary arterial hypertension (PAH), according to an ...
Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.
Ms. Khan’s term as the chair of the Federal Trade Commission ended Wednesday. In a wide-ranging interview, she discussed her aggressive approach to antitrust and its critics. By Talmon Joseph Smith ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback